Evidence map›Paper›PMID 29679770›Full record

Trial reportBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2018

Easy-to-Read Informed Consent Form for Hematopoietic Cell Transplantation Clinical Trials: Results from the Blood and Marrow Transplant Clinical Trials Network 1205 Study.

Ryan Spellecy, Sergey Tarima, Ellen Denzen, Heather Moore, Sunil Abhyankar, Peter Dawson, Amy Foley, Iris Gersten, Mitchell Horwitz, Lensa Idossa and 7 more

4 registry-linked trialsOpen access · hybridAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02081248 nacompletednot on this map

Easy-to-Read Informed Consent (ETRIC) for Hematopoietic Cell Transplantation Clinical Trials (BMT CTN #1205)

TypeinterventionalSponsorMedical College of WisconsinRan2013 to 2016Enrolled198ConditionsImprove the Informed Consent ProcessArmsConsent Form Specific Format 1, Consent Form Specific Format 2
NCT04158908 completednot on this mapstarted 2020, after this paper: background citation

Giving Information Systematically and Transparently in Lung and GI Cancer

TypeobservationalSponsorWeill Medical College of Cornell UniversityRan2020 to 2020Enrolled20ConditionsCritical Illness, Oncology, CommunicationArmsOncolo-GIST
NCT04179305 nacompletednot on this mapstarted 2020, after this paper: background citation

Giving Information Systematically and Transparently in Lung and GI Cancer Phase 2

TypeinterventionalSponsorWeill Medical College of Cornell UniversityRan2020 to 2023Enrolled37ConditionsCritical Illness, Oncology, CommunicationArmsOncolo-GIST, Usual Care Arm
NCT04407676 naunknown statusnot on this mapstarted 2020, after this paper: background citation

A Randomised Controlled Trial of Enhanced Informed Consent Compared to Standard Informed Consent To Improve Patient Understanding of Early Phase Oncology Clinical Trials

TypeinterventionalSponsorRoyal Marsden NHS Foundation TrustRan2020 to 2023Enrolled34ConditionsSolid NeoplasmsArmsSummary PIS and Online Video Modules
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. A Scoping Review on How to Make Hospitals health Literate Healthcare Organizations.International journal of environmental research and public health · 2020
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 11 institutions in 1 country.

Ryan SpellecyCenter for Bioethics and Medical Humanities, Medical College of Wisconsin, Milwaukee, Wisconsin.
Sergey TarimaCenter for Bioethics and Medical Humanities, Medical College of Wisconsin, Milwaukee, Wisconsin.
Ellen DenzenNational Marrow Donor Program, Minneapolis, Minnesota; Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota.
Heather MooreNational Marrow Donor Program, Minneapolis, Minnesota.
Sunil AbhyankarDepartment of Hematologic Malignancies and Cellular Therapies, Kansas University Medical Center, Kansas City, Kansas.
Peter DawsonThe EMMES Corporation, Rockville, Maryland.
Amy FoleyNational Marrow Donor Program, Minneapolis, Minnesota; Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota.
Iris GerstenThe EMMES Corporation, Rockville, Maryland.
Mitchell HorwitzDepartment of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, North Carolina.
Lensa IdossaNational Marrow Donor Program, Minneapolis, Minnesota.
Steven JoffeDivision of Medical Ethics, University of Pennsylvania, Philadelphia, Pennsylvania.
Naynesh KamaniAABB, Bethesda, Maryland.
Roberta KingNational Marrow Donor Program, Minneapolis, Minnesota.
Aleksandr LazaryanDepartment of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, Minnesota.
Lawrence MorrisBlood and Marrow Transplant Program, Northside Hospital, Atlanta, Georgia.
Mary M HorowitzCenter for Bioethics and Medical Humanities, Medical College of Wisconsin, Milwaukee, Wisconsin; Center for International Blood and Marrow Transplant Research, Milwaukee, Wisconsin.
Navneet S MajhailBlood and Marrow Transplant Program, Cleveland Clinic, Cleveland, Ohio. Electronic address: majhain@ccf.org.
National Marrow Donor Program · USCal Humanities · USEmmes (United States) · USAmerican Association of Blood Banks · USCleveland Clinic · USDuke University · USMedical College of Wisconsin · USNorthside Hospital · USUniversity Medical Center · USUniversity of Minnesota · USUniversity of Pennsylvania · US

Funding

Data Resource for Analyzing Blood &Marrow TransplantsU24CA076518 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI Amy M Moskop, Bronwen Shaw · 1998 to 2026
$105.2M
Blood and Marrow Transplant Clinical Trials Network DCC- The Medical College of Wisconsin, Inc.U24HL138660 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI Steven M. DeVine, Mehdi Hussain Hamadani · 2017 to 2026
$71.4M
PB vs. BMU01HL069294 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI HOROWITZ, MARY MARESCA · 2001 to 2010
$63.3M
Easy-to-read Informed Consent for HCT Clinical TrialsU10HL069294 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI HOROWITZ, MARY MARESCA · 2011 to 2016
$43.8M
BMT CTN Core - University of MinnesotaUG1HL069290 · NHLBI · UNIVERSITY OF MINNESOTA · PI Mark Juckett, Margaret L MacMillan · 2017 to 2026
$1.9M
NCI NIH HHS U24 CA076518NHLBI NIH HHS U01 HL069294NHLBI NIH HHS U10 HL069294NHLBI NIH HHS U24 HL138660NHLBI NIH HHS UG1 HL069290
6 · The paper itself

Abstract

Because of the complexity of hematopoietic cell transplant trial treatments, informed consent forms are often long and difficult to read. We evaluated a 2-column easy-to-read informed consent (ETRIC) form that incorporates elements of health literacy and readability in participants and centers participating in Blood and Marrow Transplant Clinical Trials Network (BMT CTN) clinical trials. In a randomized study 198 adult patients from 25 centers potentially eligible to participate in 4 BMT CTN interventional trials were randomized to the ETRIC form or a standard consent form for that trial. Both forms were written at no more than an eighth-grade reading level. The primary endpoint was objective comprehension score on the Quality of Informed Consent, part A (QuIC-A) instrument. In a parallel evaluation study, 2 moderators conducted semistructured interviews of 49 investigators, research staff, and institutional review board (IRB) members at 9 BMT CTN trial sites. The mean QuIC-A scores were comparable in 152 patients (77%) assessable for the primary endpoint (ETRIC form, 80.5; standard form, 81.8; P = .37). In regression analysis there was no significant association between the consent type and QuIC-A score. In the evaluation study dominant themes identified on qualitative analyses included general comfort and willingness to use the ETRIC template and that its formatting and layout enhancements would offer additional value to research participants, investigators, and IRBs. IRB language preferences and requirements, length, and prior experience with alternative consent formats were perceived as barriers. Among patients considering participation in BMT CTN clinical trials, the formatting enhancements of the ETRIC form did not alter comprehension of the trial. Despite local challenges to implementation, trial sites generally viewed the ETRIC form favorably and expressed willingness to use it over standard consent form.

Indexed as

ComprehensionConsent FormsInformed ConsentMental CompetencyAgedFemaleHematopoietic Stem Cell TransplantationHumansMaleMiddle AgedBlood and Marrow Transplant Clinical Trials Network: hematopoietic cell transplantationClinical trialsInformed consentResearch subjects

Identifiers

PMID29679770
PMCPMC6193865
OpenAlexW2802928077

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.